Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-Sm and anti-RNP antibodies.
Migliorini P, Baldini C, Rocchi V, Bombardieri S. Migliorini P, et al. Among authors: rocchi v. Autoimmunity. 2005 Feb;38(1):47-54. doi: 10.1080/08916930400022715. Autoimmunity. 2005. PMID: 15804705 Free article. Review.
Hypersensitivity reactions to tocilizumab: role of skin tests in diagnosis.
Rocchi V, Puxeddu I, Cataldo G, Del Corso I, Tavoni A, Bazzichi L, Bombardieri S, Migliorini P. Rocchi V, et al. Rheumatology (Oxford). 2014 Aug;53(8):1527-9. doi: 10.1093/rheumatology/keu181. Epub 2014 Jun 4. Rheumatology (Oxford). 2014. PMID: 24899663 No abstract available.
CCL5/RANTES, sVCAM-1, and sICAM-1 in chronic spontaneous urticaria.
Puxeddu I, Panza F, Pratesi F, Bartaloni D, Casigliani Rabl S, Rocchi V, Del Corso I, Migliorini P. Puxeddu I, et al. Among authors: rocchi v. Int Arch Allergy Immunol. 2013;162(4):330-4. doi: 10.1159/000354922. Epub 2013 Oct 25. Int Arch Allergy Immunol. 2013. PMID: 24157824
Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria.
Puxeddu I, Italiani P, Giungato P, Pratesi F, Panza F, Bartaloni D, Rocchi V, Del Corso I, Boraschi D, Migliorini P. Puxeddu I, et al. Among authors: rocchi v. Cytokine. 2013 Mar;61(3):741-3. doi: 10.1016/j.cyto.2013.01.015. Epub 2013 Feb 19. Cytokine. 2013. PMID: 23433789
Efficacy and safety of omalizumab therapy in urticaria vasculitis.
Petrelli F, Giannini D, Bilia S, Corso ID, Rocchi V, Migliorini P, Puxeddu I. Petrelli F, et al. Among authors: rocchi v. Front Allergy. 2022 Jul 22;3:952079. doi: 10.3389/falgy.2022.952079. eCollection 2022. Front Allergy. 2022. PMID: 35935020 Free PMC article.
Long-term efficacy, safety, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin (Ig) (fSCIG; HyQvia(®)) in immunodeficiency diseases: real-life data from a monocentric experience.
Angelotti F, Capecchi R, Giannini D, Mazzarella O, Rocchi V, Migliorini P. Angelotti F, et al. Among authors: rocchi v. Clin Exp Med. 2020 Aug;20(3):387-392. doi: 10.1007/s10238-020-00633-4. Epub 2020 May 8. Clin Exp Med. 2020. PMID: 32385734
18-FDG PET for large vessel vasculitis diagnosis and follow-up.
Angelotti F, Capecchi R, Giorgetti A, Erba PA, Genovesi D, Emdin M, Barison A, Manca L, Rocchi V, Migliorini P, Tavoni A. Angelotti F, et al. Among authors: rocchi v. Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):76-82. doi: 10.55563/clinexprheumatol/3cneda. Epub 2020 Dec 9. Clin Exp Rheumatol. 2021. PMID: 33337989 Free article.
75 results